Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AARTI DRUGS vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AARTI DRUGS   MYLAN
EQUITY SHARE DATA
    AARTI DRUGS
Mar-23
MYLAN
Dec-18
AARTI DRUGS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs5323,975-   
Low Rs3112,188-   
Sales per share (Unadj.) Rs293.31,829.1-  
Earnings per share (Unadj.) Rs18.049.7-  
Cash flow per share (Unadj.) Rs23.4392.1-  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.20-  
Book value per share (Unadj.) Rs128.81,978.8-  
Shares outstanding (eoy) m92.60514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.41.7 85.2%   
Avg P/E ratio x23.462.0 37.8%  
P/CF ratio (eoy) x18.07.9 229.1%  
Price / Book Value ratio x3.31.6 210.0%  
Dividend payout %5.60-   
Avg Mkt Cap Rs m39,0031,585,442 2.5%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m8040-   
Avg. sales/employee Rs Th026,887.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.1-  
INCOME DATA
Net Sales Rs m27,161941,074 2.9%  
Other income Rs m220-   
Total revenues Rs m27,182941,074 2.9%   
Gross profit Rs m3,095243,515 1.3%  
Depreciation Rs m503176,206 0.3%   
Interest Rs m37145,262 0.8%   
Profit before tax Rs m2,24222,047 10.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m578-3,507 -16.5%   
Profit after tax Rs m1,66425,554 6.5%  
Gross profit margin %11.425.9 44.0%  
Effective tax rate %25.8-15.9 -162.1%   
Net profit margin %6.12.7 225.6%  
BALANCE SHEET DATA
Current assets Rs m14,923525,495 2.8%   
Current liabilities Rs m9,330383,144 2.4%   
Net working cap to sales %20.615.1 136.2%  
Current ratio x1.61.4 116.6%  
Inventory Days Days684 6.8%  
Debtors Days Days1,16293 1,245.5%  
Net fixed assets Rs m9,290182,553 5.1%   
Share capital Rs m926501 184.8%   
"Free" reserves Rs m10,9980-   
Net worth Rs m11,9241,018,070 1.2%   
Long term debt Rs m2,0471,098,825 0.2%   
Total assets Rs m24,2142,730,861 0.9%  
Interest coverage x7.01.5 473.2%   
Debt to equity ratio x0.21.1 15.9%  
Sales to assets ratio x1.10.3 325.5%   
Return on assets %8.42.6 324.1%  
Return on equity %14.02.5 555.8%  
Return on capital %18.73.2 588.3%  
Exports to sales %31.40-   
Imports to sales %33.40-   
Net fx Rs m-8160-   
CASH FLOW
From Operations Rs m1,342195,555 0.7%  
From Investments Rs m-1,640-101,081 1.6%  
From Financial Activity Rs m165-91,101 -0.2%  
Net Cashflow Rs m-1321,620 -8.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare AARTI DRUGS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare AARTI DRUGS With: SANJIVANI PA  NATCO PHARMA  J.B.CHEMICALS  ISTREET NETWORK  TTK HEALTHCARE  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.